期刊文献+

2型糖尿病患者慢性肾脏病和蛋白尿的相关性分析 被引量:1

Association between urine albumin to creatinine ratio and chronic kidney disease in type 2 diabetic patients
原文传递
导出
摘要 目的:探讨2型糖尿病(DM2)患者中1、2级慢性肾脏病(CKD1、CKD2)和蛋白尿的相关性。方法:对591例(男性:438例;女性:153例)DM2人群进行和断面调查。采用简化MDRD公式估算肾小球滤过率(eGFR)划分CKD1和CKD2。通过随机尿中白蛋白与肌酐比值(ACR,mg/g)确定蛋白尿。结果:CKD1组无蛋白尿、微量蛋白尿、大量蛋白尿的发生率分别为78.9%、18.1%和3.0%,CKD2组分别为63.4%、24.8%和11.8%。控制年龄、性别、糖尿病病程、体重指数、血压、血脂、空腹血糖和糖化血红蛋白,Logistic回归分析显示,微量蛋白尿较无蛋白尿的糖尿病患者发生CKD2危险性的OR(95%CI)值是3.06(1.19-7.84)倍;大量蛋白尿较无蛋白尿的糖尿病患者发生CKD2危险性的OR值是6.00(2.43-14.78)倍。结论:蛋白尿与CKD的发展联系紧密,是CKD1发展为CKD2的独立危险因素。 Objective:The aim of this study was to explore the relationship between chronic kidney disease(stage 1 and stage 2,CKD1 and CKD2) and urine albumin to creatinine ratio(ACR) in type 2 diabetic patients.Methods: A total of 591 type 2 diabetic patients(438 men,153women) were enrolled in the cross-sectional survey.The CKD was divided into CKD1 and CKD2 according to the estimated estimating Glomerular Filtration Rate(eGFR)calculated by the MDRD study equation.Random Urine samples were examined for urine albumin secretion based on an ACR.Results: The prevalence rate of normoalbuminuric,microalbuminuric and macroalbuminuric were 78.9%、18.1% and 3.0% in CKD1,and were 63.4%、24.8% and 11.8% in CKD2,respectively.After adjustment for age,gender,duration of diabetes,body mass index,blood lipids,blood pressure,blood glucose and glycated hemoglobin,the ORs(95% CI) for CKD2 compared microalbuminuric with normoalbuminuric was 3.06(1.19-7.84),and compared macroalbuminuric with normoalbuminuric was 3.06(1.19-7.84),respectively.Conclusion: ACR was closely associated with the development of CKD,and was an independent risk factor for the development from CKD1 to CKD2.
出处 《中国卫生检验杂志》 CAS 2011年第5期1219-1221,共3页 Chinese Journal of Health Laboratory Technology
关键词 2型糖尿病 慢性肾脏病 尿白蛋白排泄率 Type 2 diabetic mellitus Chronic kidney disease Urine albumin to creatinine ratio
  • 相关文献

参考文献12

  • 1Coresh J, Selvin E, Stevens LA, et al, Prevalence of chronic kidney disease in the United States[J]. JAMA. 2007 Nov 7 ;298(17) :2038 - 2047.
  • 2Zhang L, Zhang P, Wang F, et al. prevalence and factoers associated with ckd:a population study from beijing[ J]. Am J Kidney Dis. 2008 Mar;51 (3) :373 -384.
  • 3Zuo L, Wang M; Beijing Hemodialysis Quality Control and Improvement Center. Current status of hemodialysis treatment in Beijing, China[J]. Ethn Dis, 2006,16(2 Suppl 2) :S2 -31 -4.
  • 4Iseki K. Chronic kidney disease in Japan [ J ]. Intern Med, 2008,47 (8) :681 -9. Epub 2008 Apr 16.
  • 5KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease [J]. Am J Kidney Dis ,2007,49 ( Suppl 2) : S12 - 154 ( P17276798 ).
  • 6Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to esti- mate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group [ J ]. Ann Intern Med, 1999, 130(6) :461 -470.
  • 7Watanabe Y, Fujii H, Aoki K, et al. A cross - sectional survey of chronic kidney disease and diabetic kidney disease in Japanese type 2 diabetic patients at four urban diabetes clinics [J]. Intern Med, 2009, 48(6) :411 -414. Epub 2009 Mar 16.
  • 8Barry M, Wall MD, Regina M, et al. High Prevalence and Diversity of Kidney Dysfunction in Patients With Type 2 Diabetes Mellitus Mellitus and Coronary Atery Disease:The BARI 2D Baseline Data [ J ]. Clinical Investigation,2010,339:401 ( 5 ) :410.
  • 9Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey [J]. Am J Kidney Dis, 2003, 41(1) :1 -12.
  • 10Adler AI, Stevens R J, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes : the United Kingdom Prospective Diabetes Study (UKPDS 64) [ J ]. Kidney Int, 2003, 63 ( 1 ) : 225 - 232.

同被引文献15

  • 1陈灏珠,林果为.实用内科学[M].北京:人民卫生出版社,2010:2389.
  • 2JANSSON P A. Endothelial dysfunction in insulin resist- ance and type 2 diabetes [ J ]. J Intern Med, 2007, 262 (2) : 178-183.
  • 3ARAKI A. Dementia and insulin resistance in patients with diabetes mellitus [ J]. Nippon Rinsho, 2010, 68 (3) : 569-574.
  • 4NAVANEETHAN S D, KELLY K R, SABBAGH F, et al. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery [J]. Obes Surg, 2010, 20 (3) : 308- 315.
  • 5WATANABE Y, FUJII H, AOKI K, et al. A cross sec- tional survey of chronic kidney disease and diabetic kid- ney disease in Japanese type 2 diabetic patients at four urban diabetes clinics [ J ]. Intern Med, 2009, 48 (6) : 411-414.
  • 6WALL B M, HARDISON R M, MOLITCH M E, et al. High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data [ J ]. Am J Med Sci, 2010, 339 (5): 401-410.
  • 7KANG Y S, CHAD R. The role of visfatin in diabetic nephropathy [ J ] . Chonnam Med J, 2011, 47 ( 3 ) : 139-143.
  • 8王晓忠,冯玉丽,占葆娥.2型糖尿病患者微量白蛋白尿与胰岛素抵抗的关系[J].中国实验诊断学,2009,13(5):633-635. 被引量:6
  • 9俞小凤,胡宏,张英姿.前列地尔联合培多普利治疗早期糖尿病肾病50例临床观察[J].职业与健康,2009,25(22):2453-2455. 被引量:2
  • 10赵丽岩.2型糖尿病肾病与血浆抵抗素及胰岛素抵抗的关系[J].职业与健康,2010,26(2):227-228. 被引量:2

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部